Outbreak response strategies with type 2-containing oral poliovirus vaccines ()

Despite exhaustive and fully-financed plans to manage the risks of globally coordinated cessation of oral poliovirus vaccine (OPV) containing type 2 (OPV2) prior to 2016, as of 2022, extensive, continued transmission of circulating vaccine-derived polioviruses (cVDPVs) type 2 (cVDPV2) remains. Notab...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalkowska, Dominika A., Wassilak, Steven G.F., Pallansch, Mark A., Burns, Cara C., Wiesen, Eric, Durry, Elias, Badizadegan, Kamran, Thompson, Kimberly M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284582/
https://www.ncbi.nlm.nih.gov/pubmed/36402659
http://dx.doi.org/10.1016/j.vaccine.2022.10.060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284582/
https://www.ncbi.nlm.nih.gov/pubmed/36402659
http://dx.doi.org/10.1016/j.vaccine.2022.10.060

Ejemplares similares